C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 5/16 (2006.01) C07K 16/32 (2006.01) C07K 16/40 (2006.01) C12P 21/08 (2006.01) C12Q 1/48 (2006.01) C12Q 1/68 (2006.01) G01N 33/53 (2006.01) G01N 33/574 (2006.01)
Patent
CA 2382655
Method and kits are provided for the detection and diagnosis of metastatic disease. More particularly, the methods and kits employ compounds that can detect EphA2, a specific epithelial cell tyrosine kinase that is overexpressed in metastatic tumor cells. In one embodiment the compound is an antibody capable of binding to an epitope of EphA2.
La présente invention concerne un procédé et des kits destinés à la détection et au diagnostic de maladie métastatique. Plus particulièrement, ces procédés et ces kits utilisent des composés pouvant détecter EphA2, une tyrosine-kinase de cellule épithéliale spécifique surexprimée dans des cellules tumorales métastatiques. Dans un des modes de réalisation, ce composé est un anticorps capable de se lier à un épitope de EphA2.
Kilpatrick Katherine E.
Kinch Michael Scott
Zantek Nicole Dodge
Glaxo Group Limited
Purdue Research Foundation
Smart & Biggar
The University Of North Carolina At Chapel Hill
LandOfFree
Antibodies as a cancer diagnostic does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antibodies as a cancer diagnostic, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antibodies as a cancer diagnostic will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1554676